Electronic Resource

The Australian and New Zealand Society for Sarcopenia and Frailty Research (ANZSSFR) sarcopenia diagnosis and management task force: Findings from the consumer expert Delphi process

التفاصيل البيبلوغرافية
العنوان: The Australian and New Zealand Society for Sarcopenia and Frailty Research (ANZSSFR) sarcopenia diagnosis and management task force: Findings from the consumer expert Delphi process
المؤلفون: Zanker, Jesse, Sim, Marc, Anderson, Kate, Balogun, Saliu, Brennan-Olsen, Sharon L., Dent, Elsa, Duque, Gustavo, Girgis, Christian M., Grossmann, Mathis, Hayes, Alan, Henwood, Tim, Hirani, Vasant, Inderjeeth, Charles, Iuliano, Sandra, Keogh, Justin, Lewis, Joshua R., Lynch, Gordon S., Pasco, Julie A., Phu, Steven, Reijnierse, Esmee M., Russell, Nicholas, Vlietstra, Lara, Visvanathan, Renuka, Walker, Troy, Waters, Debra L., Yu, Solomon, Maier, Andrea B., Daly, Robin M., Scott, David
المصدر: Research outputs 2022 to 2026
بيانات النشر: Edith Cowan University, Edith Cowan University, Research Online, Perth, Western Australia, Perth, Western Australia 2023-03-01T08:00:00Z
نوع الوثيقة: Electronic Resource
مستخلص: Objectives: To develop guidelines, informed by health-care consumer values and preferences, for sarcopenia prevention, assessment and management for use by clinicians and researchers in Australia and New Zealand. Methods: A three-phase Consumer Expert Delphi process was undertaken between July 2020 and August 2021. Consumer experts included adults with lived experience of sarcopenia or health-care utilisation. Phase 1 involved a structured meeting of the Australian and New Zealand Society for Sarcopenia and Frailty Research (ANZSSFR) Sarcopenia Diagnosis and Management Task Force and consumer representatives from which the Phase 2 survey was developed. In Phase 2, consumers from Australia and New Zealand were surveyed online with opinions sought on sarcopenia outcome priorities, consultation preferences and interventions. Findings were confirmed and disseminated in Phase 3. Descriptive statistical analyses were performed. Results: Twenty-four consumers (mean ± standard deviation age 67.5 ± 12.8 years, 18 women) participated in Phase 2. Ten (42%) identified as being interested in sarcopenia, 7 (29%) were health-care consumers and 6 (25%) self-reported having/believing they have sarcopenia. Consumers identified physical performance, living circumstances, morale, quality of life and social connectedness as the most important outcomes related to sarcopenia. Consumers either had no preference (46%) or preferred their doctor (40%) to diagnose sarcopenia and preferred to undergo assessments at least yearly (54%). For prevention and treatment, 46% of consumers preferred resistance exercise, 2–3 times per week (54%). Conclusions: Consumer preferences reported in this study can inform the implementation of sarcopenia guidelines into clinical practice at local, state and national levels across Australia and New Zealand.
مصطلحات الفهرس: community-based participatory research, geriatric assessment, sarcopenia, Medicine and Health Sciences, Public Health, text
URL: https://ro.ecu.edu.au/ecuworks2022-2026/2314
الاتاحة: Open access content. Open access content
http://creativecommons.org/licenses/by/4.0
ملاحظة: application/pdf
Research outputs 2022 to 2026
Other Numbers: ER0 oai:ro.ecu.edu.au:ecuworks2022-2026-3314
https://ro.ecu.edu.au/ecuworks2022-2026/2314
info:doi/10.1111/ajag.13164
https://ro.ecu.edu.au/context/ecuworks2022-2026/article/3314/viewcontent/The_20Australian_20and_20New_20Zealand_20Society.pdf
1380673466
المصدر المساهم: EDITH COWAN UNIV LIBR
From OAIster®, provided by the OCLC Cooperative.
رقم الانضمام: edsoai.on1380673466
قاعدة البيانات: OAIster